Zdrowie i gospodarka · 29/10/2021

FDA to Host Virtual Public Meeting on Proposed Generic Drug User Fee Amendments Reauthorization

The Food and Drug Administration (FDA) is hosting a virtual public meeting to gather public comments on proposed recommendations for reauthorizing the Generic Drug User Fee Amendments (GDUFA) for fiscal years 2023 through 2027, with a 30-day public comment period set to begin after the meeting.